Inventor
KALEKO MICHAEL
US61 patents
⚠️ This page may combine multiple inventors who share the name “KALEKO MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTHETIC BIOLOGICS INC
16 patentsUS11236319B2Feb 1, 2022
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10767171B2Sep 8, 2020
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10584326B2Mar 10, 2020
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10336995B2Jul 2, 2019
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10087433B1Oct 2, 2018
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US10011824B2Jul 3, 2018
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9783797B1Oct 10, 2017
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9695409B2Jul 4, 2017
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations84
US9464280B1Oct 11, 2016
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations74
US9404103B1Aug 2, 2016
Beta-lactamases with improved properties for therapy
SYNTHETIC BIOLOGICS INC2 citations74
US10548955B2Feb 4, 2020
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
SYNTHETIC BIOLOGICS INC3 citations73
US10046035B2Aug 14, 2018
Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGICS INC2 citations71
US9744221B2Aug 29, 2017
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGICS INC3 citations71
US10987410B2Apr 27, 2021
Alkaline phosphatase formulations
SYNTHETIC BIOLOGICS INC3 citations68
US11542510B2Jan 3, 2023
E. coli-based production of beta-lactamase
SYNTHETIC BIOLOGICS INC0 citations59
US11034966B2Jun 15, 2021
E. coli-based production of beta-lactamase
SYNTHETIC BIOLOGICS INC0 citations59
NOVARTIS AG
11 patentsUS6864085B2Mar 8, 2005
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG24 citations95
US7202079B2Apr 10, 2007
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG22 citations92
US7442551B2Oct 28, 2008
Lentiviral packaging constructs
NOVARTIS AG16 citations91
US7070993B2Jul 4, 2006
Lentiviral packaging constructs
NOVARTIS AG16 citations91
US6608038B2Aug 19, 2003
Methods and compositions for treatment of diabetes and related conditions via gene therapy
NOVARTIS AG47 citations88
US7662621B2Feb 16, 2010
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG4 citations73
US7198793B2Apr 3, 2007
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG6 citations73
US7153512B2Dec 26, 2006
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG3 citations73
US7125712B2Oct 24, 2006
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG5 citations73
US7785877B2Aug 31, 2010
Bovine immunodeficiency virus (BIV) based vectors
NOVARTIS AG3 citations71
US7700342B2Apr 20, 2010
Lentiviral packaging constructs
NOVARTIS AG3 citations61
THERIVA BIOLOGICS INC
8 patentsUS11608494B2Mar 21, 2023
Beta-lactamases with improved properties for therapy
THERIVA BIOLOGICS INC2 citations84
US12274740B2Apr 15, 2025
Microbiome protection from oral antibiotics
THERIVA BIOLOGICS INC0 citations62
US11883474B2Jan 30, 2024
Microbiome protection from oral antibiotics
THERIVA BIOLOGICS INC0 citations62
US12178917B2Dec 31, 2024
Beta-lactamase formulations and uses thereof
THERIVA BIOLOGICS INC0 citations61
US11654184B2May 23, 2023
Alkaline phosphatase agents for treatment of radiation disorders
THERIVA BIOLOGICS INC1 citations61
US12318434B2Jun 3, 2025
Alkaline phosphate-based oncology treatments
THERIVA BIOLOGICS INC0 citations60
US11944669B2Apr 2, 2024
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
THERIVA BIOLOGICS INC0 citations60
US11981899B2May 14, 2024
E. coli-based production of beta-lactamase
THERIVA BIOLOGICS INC0 citations59
SYNTHETIC BIOLOGIES INC
4 patentsUS11517614B2Dec 6, 2022
Microbiome protection from oral antibiotics
SYNTHETIC BIOLOGIES INC0 citations61
US11123413B2Sep 21, 2021
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
SYNTHETIC BIOLOGIES INC0 citations61
US11596674B2Mar 7, 2023
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
SYNTHETIC BIOLOGIES INC0 citations59
US11338020B2May 24, 2022
Alkaline phosphatase agents for treatment of neurodevelopmental disorders
SYNTHETIC BIOLOGIES INC0 citations59
WELLSTAT IMMUNOTHERAPEUTICS LLC
3 patentsUS10415026B2Sep 17, 2019
Complement factor B analogs and their uses
WELLSTAT IMMUNOTHERAPEUTICS LLC2 citations69
US9533028B2Jan 3, 2017
Complement factor B analogs and their uses
WELLSTAT IMMUNOTHERAPEUTICS LLC2 citations69
US11001822B2May 11, 2021
Complement factor B analogs and their uses
WELLSTAT IMMUNOTHERAPEUTICS LLC0 citations59
GENETIC THERAPY INC
2 patentsSYNTHETIC BIOLOG INC
2 patentsGENETIC THERAPHY INC
1 patentCELL GENESYS INC
1 patentCHEN CHANGHUNG
1 patentLUO TIANCI
1 patentShowing the top 50 of 61 patents by PatentIndex Score.